Vijay Kasturi

Dr. Vijay Kasturi, Vice President, Medical Affairs, brings more than 25 years of experience establishing and executing global and regional strategies that have brought innovative new treatment options to patients in hematology and oncology. Prior to joining AVEO, Dr. Kasturi was Senior Vice President of Scientific Affairs at FerGene, where he also led both Medical Affairs and Clinical Development. He has also led U.S. Medical Affairs, Oncology for EMD Serono where he had broad leadership responsibilities, including external stakeholder management, evidence generation, medical education and publication strategy. During his time with EMD Serono, Vijay also developed and managed the global medical strategy and launch plan for the company’s anti-PD-L1 agent (avelumab), including indications in Merkel cell, urothelial, and kidney cancer.

Earlier in his career, Dr. Kasturi served as an Assistant Professor of Medicine, Division of Hematology-Oncology at the University of Massachusetts Medical School and was the program leader for genitourinary oncology at UMass Memorial Cancer Center. He trained in Hematology-Oncology at the National Cancer Institute and worked as an investigator and physician at the National Cancer Institute and at Dartmouth Hitchcock Medical Center.